Version history

{
  "session_id": "sess_SDA-2026-04-10-gap-20260410-095113",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "mini-max",
  "action": "propose",
  "content": "\n\n# Mechanistic Hypotheses: Layer-Specific Synaptic Vulnerability in Alzheimer's Progression\n\n## Analytical Framework\n\nThe SEA-AD Atlas data reveals a convergent pattern: layer-specific vulnerability correlates with coordinated glial activation (microglia/astrocyte), excitatory synapse loss, and APOE4-mediated genetic risk. These correlation coefficients suggest moderate-strong associations, providing sufficient evidence to formulate mechanistic testable hypotheses.\n\n---\n\n## Hypothesis 1: Complement \"Gradient Threshold\" Model of Synaptic Pruning\n\n**Description:** The C1QA layer-specific gradient (0.646) suggests a non-linear relationship between complement cascade activation and synaptic protection. Vulnerable layers may exhibit reduced local expression of complement regulatory proteins (CD46, CD55, CRRY), creating a \"gradient threshold\" below which C1q-mediated elimination of synapses accelerates. This is consistent with findings that complement proteins C1q and C3 localize to vulnerable synapses in AD brain.\n\n**Target Gene/Protein:** C1QA, CD46 (MCP), CD55 (DAF)\n\n**Confidence Score:** 0.72\n\n---\n\n## Hypothesis 2: TREM2-Dependent Phagocytic Dysregulation Creates Layer-Specific \"Synaptic Debris Accumulation\"\n\n**Description:** TREM2 DAM upregulation (0.576) indicates microglial recruitment to damaged areas. However, TREM2 variants (including R47H) impair recognition of phospholipid \"eat-me\" signals on stressed synapses. This hypothesis proposes that layers with high metabolic demand (Layer V pyramidal neurons) generate more synaptic stress signals but receive impaired TREM2-mediated phagocytic clearance, leading to accumulation of toxic debris that triggers excitotoxicity and VGLUT1 loss.\n\n**Target Gene/Protein:** TREM2, TREM2-ligands (phosphatidylserine, APOE)\n\n**Confidence Score:** 0.78\n\n---\n\n## Hypothesis 3: VGLUT1 Loss via Layer-Specific Calcium-Permeable AMPAR Upregulation\n\n**Description:** VGLUT1 excitatory neuron loss (0.567) may result from calpain-mediated proteolysis triggered by calcium-permeable AMPA receptor (CP-AMPAR) insertion. Evidence suggests CP-AMPARs are upregulated in vulnerable neuronal populations during early AD. This hypothesis posits that layer-specific CP-AMPAR expression patterns—driven by reduced neuronal钾 channel activity or NMDA receptor dysfunction—create differential vulnerability to excitotoxic VGLUT1 degradation.\n\n**Target Gene/Protein:** GRIK2 (KA receptor), CALPAIN1/2, VGLUT1 (SLC17A7)\n\n**Confidence Score:** 0.65\n\n---\n\n## Hypothesis 4: APOE4 Glial Dysregulation Destabilizes Layer-Specific Metabolic Support\n\n**Description:** APOE4 glial dysregulation (0.56) is mechanistically linked to impaired lipid trafficking and synaptic support functions. Astrocyte-derived APOE4 demonstrates reduced ability to deliver lipid species necessary for synaptic vesicle recycling and mitochondrial function. This hypothesis proposes that APOE4-expressing astrocytes fail to maintain metabolic coupling with layer-specific neuronal populations, particularly Layer II/III pyramidal neurons which have high energy demands, leading to \"pseudo-hypoxic\" states and eventual VGLUT1 loss.\n\n**Target Gene/Protein:** APOE, ABCA1, LDLR, GFAP (indirect via astrocyte dysfunction)\n\n**Confidence Score:** 0.81\n\n---\n\n## Hypothesis 5: GFAP Reactive Astrocytosis Triggers Layer-Specific \"A2-to-A1\" Transition\n\n**Description:** GFAP elevation (0.536) is the canonical marker of reactive astrogliosis, but emerging evidence indicates astrocytes can adopt neurotoxic (A1) or neuroprotective (A2) states. This hypothesis proposes that layer-specific factors (complement deposition from C1QA, TREM2-mediated microglial signaling) induce a selective A1 transition in astrocytes surrounding vulnerable layers, causing loss of glutamate uptake capacity (via EAAT2 downregulation) and triggering excitatory synapse loss.\n\n**Target Gene/Protein:** GFAP, C3 (A1 marker), LCN2, EAAT2 (SLC1A2)\n\n**Confidence Score:** 0.68\n\n---\n\n## Hypothesis 6: Multi-Glial \"Vicious Cycle\" Amplifies Layer-Specific Vulnerability\n\n**Description:** The convergence of C1QA, TREM2, APOE4, and GFAP dysregulation suggests a reinforcing feedback loop. This hypothesis proposes: (1) APOE4 impairs TREM2 function in microglia → (2) reduced phagocytosis increases C1Q deposition → (3) complement activation triggers astrocyte A1 transition → (4) A1 astrocytes lose glutamate homeostasis → (5) extracellular glutamate damages local synapses. The layer-specificity emerges from where this cycle first crosses a critical threshold, possibly determined by baseline metabolic demand.\n\n**Target Gene/Protein:** Network model: APOE4 → TREM2 → C1Q → Astrocyte C3 → EAAT2/SLC1A2\n\n**Confidence Score:** 0.73\n\n---\n\n## Hypothesis 7: APOE4 × TREM2 Genetic Interaction Defines Glial \"Synaptic Support Reserve\"\n\n**Description:** APOE4 and TREM2 are known to interact genetically (TREM2 ligands include APOE). This hypothesis proposes that the combined presence of APOE4 risk allele and TREM2 variant alleles defines a \"synaptic support reserve\" that varies by cortical layer based on baseline synaptic density and activity. Layers with high VGLUT1 expression (excitatory synapses) and high metabolic demand have lower reserve, explaining their preferential vulnerability when dual genetic risk is present.\n\n**Target Gene/Protein:** APOE-TREM2 interaction axis, synaptic proteins (VGLUT1, PSD95)\n\n**Confidence Score:** 0.70\n\n---\n\n## Summary Table\n\n| Hypothesis | Primary Mechanism | Key Biomarkers | Confidence |\n|------------|-------------------|----------------|------------|\n| H1 | Complement gradient threshold | C1QA, CD46 | 0.72 |\n| H2 | TREM2 phagocytic failure | TREM2, \"eat-me\" signals | 0.78 |\n| H3 | CP-AMPAR excitotoxicity | VGLUT1, CALPAIN | 0.65 |\n| H4 | APOE4 metabolic failure | APOE, GFAP | 0.81 |\n| H5 | Astrocyte A1 transition | GFAP, C3, EAAT2 | 0.68 |\n| H6 | Multi-glial vicious cycle | Network model | 0.73 |\n| H7 | APOE4×TREM2 interaction | APOE, TREM2, VGLUT1 | 0.70 |\n\n---\n\n## Recommended Experimental Approaches\n\n1. **Spatial transcriptomics** to map C1Q regulators across cortical layers\n2. **iPSC-derived assembloids** with layer-specific neurons and APOE4/TREM2 genotypes\n3. **In situ imaging mass cytometry** for simultaneous measurement of all five biomarkers\n4. **CRISPRi screens** targeting complement regulators in layer-specific neurons",
  "tokens_used": "1591"
}